TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Platycodin D, Venetoclax
Phytochemical Name Platycodin D (PubChem CID: 162859 )
Anticancer drug Name Venetoclax (PubChem CID: 49846579 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 962
Pair Name Platycodin D, Venetoclax
Disease Info [ICD-11: 2A60.Z] Acute myeloid leukemia Investigative
Biological Phenomena Induction-->Blockade of cell cycle in G0/G1 phase
Gene Regulation Down-regulation Phosphorylation AKT1 hsa207
Up-regulation Expression BAK1 hsa578
Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Up-regulation Expression BCL-xL hsa598
Up-regulation Expression BIM hsa10018
Up-regulation Cleavage CASP3 hsa836
Down-regulation Expression CYCS hsa54205
Down-regulation Phosphorylation GSK3B hsa2932
Down-regulation Phosphorylation MAPK1 hsa5594
Up-regulation Expression MCL1 hsa4170
Up-regulation Cleavage PARP1 hsa142
Down-regulation Phosphorylation S6K1 KEGG ID N.A.
In Vitro Model MV4-11 Childhood acute monocytic leukemia Homo sapiens (Human) CVCL_0064
THP-1 Childhood acute monocytic leukemia Homo sapiens (Human) CVCL_0006
Result Platycodin D may be a potent therapeutic candidate for the treatment of AML
03. Reference
No. Title Href
1 Platycodin D induces apoptotic cell death through PI3K/AKT and MAPK/ERK pathways and synergizes with venetoclax in acute myeloid leukemia. Eur J Pharmacol. 2023 Oct 5;956:175957. doi: 10.1016/j.ejphar.2023.175957. Click
It has been 26786 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP